Research Article
GABRG2 C588T Polymorphism Is Associated with Idiopathic Generalized Epilepsy but Not with Antiepileptic Drug Resistance in Pakistani Cohort
Table 2
Demographic and clinical attributes of the participants.
| | Variable | IGEs group
88 (%) | Control group
84 (%) | ASM-resistant group
55 (%) |
| | Age in years () | | | | | Age at onset in years | | | | | Gender | | Male | 47 (53.4090) | 45 (53.57) | 31 (56.36) | | Female | 41 (46.59) | 39 (46.42) | 24 (43.63) | | Family history | | First-degree relatives | 17 (19.31) | — | 11 (20) | | Second-degree relatives | 9 (10.22) | — | 21 (38.18) | | Seizure type | | Myoclonic jerks | 17 (19.31) | — | 8 (14.5) | | Generalized tonic clonic seizures | 32 (36.36) | — | 29 (52.72) | | Absence seizures | 27 (30.68) | — | 19 (34.54) | | Tonic | 9 (10.22) | — | 9 (16.36) | | Juvenile absence seizures | 15 (17.045) | — | 7 (12.72) | | Treatment | | Monotherapy | 35 (39.77) | — | 6 (10.90) | | Polytherapy | 53 (60.22) | — | 49 (89.09) |
|
|
